Efficacy Study of Inecalcitol in Combination with Decitabine in Acute Myeloid Patients Unfit for Standard Chemotherapy
The goal of this clinical research study is to learn if adding the study drug inecalcitol to treatment with decitabine can help to control acute myeloid leukemia (AML) in patients for whom standard chemotherapy is not recommended. The safety of this drug combination will also be studied.
Treatment Location: N/A
IRB Review and Approval Date: 09/13/2016
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
For general questions about clinical trials: